Despite the above, guides from the U.S. Preventive Services Task Force do not recommend genetic screening for hereditary hemochromatosis because they do not have a balanced cost-benefit 26. Nevertheless, some recent publications have postulated that genetic screening should be carried out when patients show levels of ferritin of over 1000 micro/lit. Studies with greater statistical power are still necessary 24, 25.
Aunque las guías del U.S. Preventive Services Task Force no recomiendan el tamizaje genético para hemocromatosis hereditaria por no tener un balance costo beneficio 26, algunas publicaciones recientes han postulado que debe realizarse tamizaje a pacientes que tengan niveles de ferritina por encima de 1.000 micro/lit; sin embargo, son necesarios estudios de mayor poder estadístico 24, 25.